ChromoSeq
A Prospective Study of Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in MDS
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Observational Trial
- Enrollment
- 60 patients (estimated)
- Sponsors
- Washington University School of Medicine
- Collaborators
- National Cancer Institute (NCI), Edward P. Evans Foundation
- Tags
- Genetic Sequencing, Laboratory Assay
- Trial Type
- Observational
- Last Update
- 4 months ago
- SparkCures ID
- 1529
- NCT Identifier
- NCT05434598
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.